Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer
Clinical trial NCT01104675 · COMPLETED
Trial details
- NCT number
- NCT01104675
- Sponsor
- CASI pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-08-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.